Threats to scientific advancement in clinical practice

Spine

Volumn 32, Issue 11 SUPPL., 2007, Pages

  Weinstein, James N ^a,b   Morgan, Tamara Shawver ^c  

^a DARTMOUTH INSTITUTE FOR HEALTH POLICY AND CLINICAL PRACTICE   (United States)

^b DARTMOUTH MEDICAL SCHOOL   (United States)

^c DARTMOUTH HITCHCOCK MEDICAL CENTER   (United States)

Author keywords

Conflict of interest; Ethics; Health care reform

Indexed keywords

CLINICAL PRACTICE; DIAGNOSTIC TEST; ETHICS; GOVERNMENT; HEALTH; HEALTH CARE; HEALTH CARE COST; HEALTH CARE SYSTEM; INDUSTRY; MEDICAL LIABILITY; PHYSICIAN; PRIORITY JOURNAL; REVIEW; TECHNOLOGY;

BIOMEDICAL RESEARCH; CONFLICT OF INTEREST; HUMANS; INDUSTRY; PHYSICIANS;

EID: 34248348209     PISSN: 03622436     EISSN: 15281159     Source Type: Journal    
DOI: 10.1097/BRS.0b013e318053d4fc     Document Type: Review

References (26)

1. Kassirer J. On the Take: How America's Complicity With Big Business Can Endanger Your Health. New York, NY: Oxford University Press; 2005.
2. Organization WH. World Health Report 2000: Health Systems-Improving Performance. Geneva, Switzerland: World Health Organization; 2000.
3. Freeman BJ, Fraser RD, Cain CM, et al. A randomized, double-blind, controlled trial: Intradiscal electrothermal therapy versus placebo for the treatment of chronic discogenic low back pain. Spine 2005;30:2369-77.
4. Malchau H. Introducing new technology: A stepwise algorithm. Spine 2000;25:285.
5. Saal JA, Saal JS. Intradiscal electrothermal treatment for chronic discogenic low back pain: A prospective outcome study with minimum 1-year follow-up. Spine 2000;25:2622-7.
6. Freedman BA, Cohen SP, Kuklo TR, et al. Intradiscal electrothermal therapy (IDET) for chronic low back pain in active-duty soldiers: 2-year follow-up. Spine J 2003;3:502-9.
7. Pauza KJ, Howell S, Dreyfuss P, et al. A randomized, placebo-controlled trial of intradiscal electrothermal therapy for the treatment of discogenic low back pain. Spine J 2004;4:27-35.
8. Goffman W. In: Praeger A, ed. Coping With Biomedical Literature. Rosemont, IL: American Association of Orthopaedic Surgeons; 1981:31-46.
9. Lock S. Information overload: Solution by quality? Br Med J (Clin Res Ed) 1982;284:1289-90.
10. Rorabeck CH, Bourne RB, Laupacis A, et al. A double-blind study of 250 cases comparing cemented with cementless total hip arthroplasty. Cost-effectiveness and its impact on health-related quality of life. Clin Orthop Relat Res 1994;298:156-64.
11. Katz JN, Barrett J, Mahomed NN, et al. Association between hospital and surgeon procedure volume and the outcomes of total knee replacement. J Bone Joint Surg Am 2004;86-A:1909-16.
12. Katz JN, Losina E, Barrett J, et al. Association between hospital and surgeon procedure volume and outcomes of total hip replacement in the United States Medicare population. J Bone Joint Surg Am 2001;83-A:1622-9.
13. Bozic K, Katz P, Cisternas M, et al. Hospital resource utilization for primary and revision total hip arthroplasty. J Bone Joint Surg Am 2005;87:570-6.
14. Bozic K. In: Weinstein J, ed. 2004.
15. Weinstein J, Clay K. The Patient as a Catalyst for Change: Evidence and Shared Decision-Making. The Institute of Medicine. Roundtable on Evidenced-Based Medicine, The Learning Healthcare System. In Press.
16. Weinstein J, Clay K, Kearing S, et al. Informed patient choice: Assessment of risk/benefit tradeoffs for surgical procedures and medical devices. Health Aff (Millwood). In Press.
17. Weinstein JN, Bronner KK, Morgan TS, et al. Trends and geographic variations in major surgery for degenerative diseases of the hip, knee, and spine. Health Aff (Millwood) 2004;(suppl Web exclusives):VAR81-9.
18. Fisher ES, Wennberg DE, Stukel TA, et al. The implications of regional variations in Medicare spending. Part 1: The content, quality, and accessibility of care. Ann Intern Med 2003;138:273-87.
19. Fisher ES, Wennberg DE, Stukel TA, et al. The implications of regional variations in Medicare spending. Part 2: Health outcomes and satisfaction with care. Ann Intern Med 2003;138:288-98.
20. Studdert DM, Mello MM, Brennan TA. Financial conflicts of interest in physicians' relationships with the pharmaceutical industry-Self-regulation in the shadow of federal prosecution. N Engl J Med 2004;351:1891-900.
21. Blumenthal D. Doctors and drug companies. N Engl J Med 2004;351:1885-90.
22. Weinfurt KP, Dinan MA, Allsbrook JS, et al. Policies of academic medical centers for disclosing financial conflicts of interest to potential research participants. Acad Med 2006;81:113-8.
23. Shah RV, Albert TJ, Bruegel-Sanchez V, et al. Industry support and correlation to study outcome for papers published in Spine. Spine 2005;30:1099-104.
24. Weinstein J. Information to authors. Spine 2001;26:122-4.
25. Andersson G, Boden S, Bridwell K, et al. Breaking down the barriers to restore public confidence: Disclosure. Spine 2002;27:6-10.
26. Thompson DF. Understanding financial conflicts of interest. N Engl J Med 1993;329:573-6.